Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Babylon Acquires Higi to Extend its Digital-First Healthcare Platform to Millions of People in the U.S.
Babylon today announced the closing on December 31, 2021 of its acquisition of Higi SH […]
Babylon Announces New Collaboration with Microsoft to Drive Healthcare Innovation and Improve Health Access and Affordability Around the World
Babylon, a world leading digital-first, value-based care company today announced a collaboration with Microsoft to […]
Royal Wolverhampton NHS Trust (RWT) and Babylon bring digital-first, value-based healthcare to over 55,000 people across Wolverhampton
Royal Wolverhampton NHS Trust (RWT) and Babylon today announced they have extended their partnership to bring […]
Peer-reviewed Research Finds Babylon's Digital-first Model of Primary Care is Associated With Lower Significantly NHS Hospital Care Costs
Researchers at Babylon, a leading digital-first value-based healthcare company, have found that members of Babylon’s […]
Babylon Hires Former White House Health Official Darshak Sanghavi as New Chief Medical Officer
Babylon today announced the hiring of Darshak Sanghavi, MD as the company’s new Global Chief […]
Babylon: Meet the Largest Digital-First, Value-Based Care Provider in the United States
Babylon today announced that its recent strategic partnerships and acquisitions — combined with significant organic […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more